Brucellosis Vaccine Prize Competition now accepting applications

The newly launched US $30 million Brucellosis Vaccine Prize Competition is open to applicants starting September 2016 for up to one year. The initiative, which is funded by AgResults and Implemented by GALVmed, is aimed at providing incentives to animal health, pharmaceutical companies and research institutes to develop a B. melitensis vaccine against brucellosis, which will be used mainly in developing countries. The prize – one of the largest of its kind – will go towards funding innovative solutions from the private sector to intractable development challenges.

How can you apply?
Register for the competition 

First-ever licensed vaccine against major cause of epilepsy in developing world

GALVmed's partnership with Professor Marshall Lightowlers at the University of Melbourne and Indian Immunologicals Ltd has led to the first-ever porcine cysticercosis vaccine. The TSOL18 vaccine technology, known as Cysvax®, will be for sale in India through Indian Immunological Limited by the end of 2016. 

Read more

Media coverage 
Times article
Animal Pharm article

From factory to farmer: Creating a sustainable Newcastle Disease vaccine supply chain

For farmers to benefit from animal health products, there has to be a reliable and sustainable supply chain to deliver the products. GALVmed is working with Hester Biosciences Ltd. in India to set up a sustainable supply chain for the ND vaccine from manufacturer to the smallholder farmers in rural areas.

Watch the video

East Africa Community Regulatory Harmonisation update

Since 2012, GALVmed has worked with the EAC Secretariat and national drug regulatory authorities (NRAs) in EAC Partner States  to harmonise requirements for veterinary vaccine registration. A technical working group was formed with representatives from NRAs of Kenya, Tanzania, Uganda, Rwanda and Burundi to develop technical documents for harmonised registration of veterinary immunologicals in the EAC leading to Mutual Recognition.
Read about GALVmed’s work on regulatory harmonisation

Featured on our blog 


GALVmed in the news 

The Times and Animal Pharm offered exclusive coverage of the PC vaccine registration.
Our publications
Our marketing materials
Our Twitter page
Our Facebook page
Copyright © 2016 GALVmed, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list

Email Marketing Powered by Mailchimp